The multiple sclerosis is an autoimmune disease which has seen a significant and impressive development in treatment and new drugs with a massive impact on the management of patients but also on the healthy system.
The possibility to use new techniques and new protocols of management will be discussed in this event from the neuroimaging studies to the liquoral biomarkers.
The opportunity to meet experiences of countries - which are closed to this area - is an additional goal we aiming to in order to a possible future European collaboration.